With results season in full flow and some great numbers issued from many AIM companies we follow it’s increasingly hard to pick out the highlights. However, it wasn’t all good news from AIM this week and our weekly summary…
In March 2015, we reported on OptiBiotix Health, an exciting company specialising in biotechnological research. It has now been just over a year since the Group first arrived on AIM,…
With 2014 seeing the highest number of new admissions to AIM since the glory days of 2007, and 2015 also looking encouraging for the junior market, it’s a good time…
Today OptiBiotix, a life sciences business, has announced that it has signed a third agreement with NIZO Food Research BV ("NIZO"), the contract food research organisation based in the Netherlands.
OptiBiotix Health PLC (AIM: OPTI) was formed in March 2012 and arrived on AIM in August 2014 via a reverse takeover. It operates in one of the most progressive areas…
Access the all latest company comments on Investor's Champion.
Not yet registered? It's free to register. Register now.
Register on Investor's Champion
Access the all latest company comments on Investor's Champion.
Premium Content
Premium content provides more in-depth information on fascinating investment stories and research to help make your money go further.
Access Premium Content through individual credits (we only want you to read what you are interested in) or through an annual subscription, which works out as only 25p per day – a small price to guide you through the investing maze!
Subscription
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
In depth coverage of many of the world’s great companies
Breaking news on potential upcoming disasters
Unique insights from our top research team
Credits
Get access to our premium content for as little as £3.20 per article.